Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor CCR5

Details for Australian Patent Application No. 2005257708 (hide)

Owner AstraZeneca AB

Inventors Tucker, Howard; Faull, Alan

Agent Freehills

Pub. Number AU-A-2005257708

PCT Pub. Number WO2006/001752

Priority 0401656-4 24.06.04 SE

Filing date 20 June 2005

Wipo publication date 5 January 2006

International Classifications

C07D 211/30 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

Event Publications

21 December 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as modulators of chemokine receptor CCR5

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/001752 Priority application(s): WO2006/001752

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257709-New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt

2005257707-Chemical compounds I